The role of corticosteroids in severe community-acquired pneumonia: a systematic review

Jorge IF Salluh¹^,2 , Pedro Póvoa³, Márcio Soares¹, Hugo C Castro-Faria-Neto², Fernando A Bozza⁴ and Patrícia T Bozza²

¹Intensive Care Unit, Instituto Nacional de Câncer, Praça Cruz Vermelha, 23, 10 andar – Centro, Rio de Janeiro-RJ, Brazil 20230-130

²Immunopharmacology Laboratory, Instituto Oswaldo Cruz, FIOCRUZ, Av. Brasil, 4365, Rio de Janeiro-RJ, Brazil 21045-900

³Medical Intensive Care Unit, Hospital de São Francisco Xavier. Centro Hospitalar de Lisboa Ocidental, Estrada do Forte do Alto do Duque, CEP 1449-005 Lisboa, Portugal

⁴Instituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil, 4365, Rio de Janeiro-RJ, Brazil 21045-900

author email corresponding author email

Critical Care 2008, 12:434doi:10.1186/cc7107

The electronic version of this article is the complete one and can be found online at: http://ccforum.com/content/12/6/434

Published:

7 November 2008

Correction

Following the publication of the above article [1], we noticed that in Table 1, concerning the data of the study from Garcia-Vidal the dose of methylprednisolone is not 14.5 mg/day but 45 mg/day.

Table 1. Recent literature on the role of corticosteroids in severe community-acquired pneumonia

Competing interests

The authors declare that they have no competing interests.

References

Salluh JI, Povoa P, Soares M, Castro-Faria-Neto HC, Bozza FA, Bozza PT: The role of corticosteroids in severe community-acquired pneumonia: a systematic review.
Crit Care 2008, 12:R76. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text

The role of corticosteroids in severe community-acquired pneumonia: a systematic review

Correction

Competing interests

References

Have something to say? Post a comment on this article!